Radar on Drug Benefits

News Briefs

✦ Highmark Inc. said on Sept. 21 that it entered into an outcomes-based payment agreement with AstraZeneca PLC for Fasenra (benralizumab), which is an add-on treatment for patients age 12 and older with severe ast...
0 Comments
© 2024 MMIT

Express Scripts Nixes Cosentyx, Neulasta in 2021 Formularies

Cigna Corp.-owned PBM Express Scripts says it will exclude nearly 150 brand medications in its 2021 National Preferred Formulary. But one consultant says only a handful of the exclusions — notably, Novartis Pharma...
0 Comments
© 2024 MMIT

Cash-Strapped States Eye Reverse-Auction PBM Procurement

With the economic fallout from COVID-19 driving billions of dollars in projected state budget shortfalls over the next few years, officials around the country are taking a hard look at how to cut costs. Against that...
0 Comments
© 2024 MMIT

Prime Therapeutics Rolls Out New Real Time Benefit Tool

With the deadline approaching for Medicare Part D plans to implement a Real Time Benefit Tool (RTBT) — which informs prescribers when lower-cost alternative therapies are available under a beneficiary’s drug ben...
0 Comments
© 2024 MMIT

One Drug Pricing Order Is Still Missing; Another Draws Fire

A promised executive order that would tie drug prices to their costs in other countries has yet to emerge, although President Donald Trump has promoted the order as part of his re-election campaign. Meanwhile, payer...
0 Comments
© 2024 MMIT

Proposed Rule Aims to Hasten Access to Breakthrough Medical Devices

Carrying out another directive from President Trump’s Medicare-focused executive order issued last fall, CMS on Aug. 31 released a proposed rule that aims to fast-track Medicare coverage of certain innovative FDA ...
0 Comments
© 2024 MMIT

Most Medicare Part D Plans Incentivize Use of Generics, Study Finds

For medications with both brand-name and generic versions, an overwhelming majority of Medicare Part D plans encouraged the use of generics over their brand-name equivalents in 2019, according to a study published i...
0 Comments
© 2024 MMIT

News Briefs

✦ HHS on Sept. 9 issued guidance that authorizes state-licensed pharmacists to order and administer COVID-19 vaccines to people ages 3 and up — when they’re authorized or licensed by the FDA and made available...
0 Comments
© 2024 MMIT

Experts: USPS Slowdown Is Unlikely to Disrupt Most Rx Fills

The recent, sudden disruption of U.S. Postal Service (USPS) deliveries has caused concern about people receiving their medications later than they normally would. While news reports and statements by lawmakers indic...
0 Comments
© 2024 MMIT

UnitedHealth Drops Descovy as Generic Shakes Up PrEP Class

UnitedHealthcare is dropping coverage in its commercial plan formularies for Gilead Sciences, Inc.’s HIV pre-exposure prophylaxis (PrEP) medication Descovy (emtricitabine and tenofovir alafenamide), steering patie...
0 Comments
© 2024 MMIT